- Home
- GEO vs CNTA Comparison
GEO vs CNTA Comparison
Compare GEO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEO
- CNTA
- Stock Information
- Founded
- GEO 1984
- CNTA 2020
- Country
- GEO United States
- CNTA United Kingdom
- Employees
- GEO N/A
- CNTA N/A
- Industry
- GEO Homebuilding
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- GEO Consumer Discretionary
- CNTA Health Care
- Exchange
- GEO Nasdaq
- CNTA Nasdaq
- Market Cap
- GEO 3.9B
- CNTA 2.3B
- IPO Year
- GEO 1994
- CNTA 2021
- Fundamental
- Price
- GEO $28.28
- CNTA $17.50
- Analyst Decision
- GEO Buy
- CNTA Strong Buy
- Analyst Count
- GEO 4
- CNTA 7
- Target Price
- GEO $34.50
- CNTA $23.71
- AVG Volume (30 Days)
- GEO 2.5M
- CNTA 581.0K
- Earning Date
- GEO 02-13-2025
- CNTA 11-12-2024
- Dividend Yield
- GEO N/A
- CNTA N/A
- EPS Growth
- GEO N/A
- CNTA N/A
- EPS
- GEO 0.27
- CNTA N/A
- Revenue
- GEO $2,424,264,000.00
- CNTA $6,853,000.00
- Revenue This Year
- GEO $1.44
- CNTA N/A
- Revenue Next Year
- GEO $12.34
- CNTA N/A
- P/E Ratio
- GEO $103.15
- CNTA N/A
- Revenue Growth
- GEO N/A
- CNTA N/A
- 52 Week Low
- GEO $10.46
- CNTA $6.65
- 52 Week High
- GEO $29.86
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- GEO 59.08
- CNTA 53.43
- Support Level
- GEO $27.39
- CNTA $15.45
- Resistance Level
- GEO $28.78
- CNTA $18.00
- Average True Range (ATR)
- GEO 1.28
- CNTA 1.14
- MACD
- GEO -0.25
- CNTA -0.05
- Stochastic Oscillator
- GEO 79.15
- CNTA 76.78
About GEO Geo Group Inc (The) REIT
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.